Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.
Press releases published on August 27, 2025
Tilray Brands Successfully Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
GlobeNewswire
·
August 27, 2025
NEW YORK and LEAMINGTON, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
IRVINE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences: Wells Fargo 20th Annual Healthcare Conference on Wednesday, …
Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering
GlobeNewswire
·
August 27, 2025
Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, …
Jasper Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell …
Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 27, 2025
MOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the …
Supernus Pharmaceuticals to Participate in September Investor Conferences
GlobeNewswire
·
August 27, 2025
ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today …
CooperCompanies Announces Third Quarter 2025 Results
GlobeNewswire
·
August 27, 2025
SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025. Revenue increased 6% year-over-year to $1,060.3 …
Anaptys Announces Participation in September Investor Conferences
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of …
Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
GlobeNewswire
·
August 27, 2025
WESTBROOK, Maine, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the closing of an underwritten public offering of 1,750,000 shares of common …
Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025
GlobeNewswire
·
August 27, 2025
AURORA, Colo., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (“Bespoke” or the “Company”) (OTCQB: BSPK), today reported its financial results for the quarter ended June 30, 2025. Financial results are reported in accordance with U.S. generally …
Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …
Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico
GlobeNewswire
·
August 27, 2025
MILAN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., an Italian pharmaceutical manufacturer, and EarlyHealth Group, a global pharmaceutical service provider, have announced the expansion of their strategic partnership to improve access to …
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
August 27, 2025
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …
MannKind to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with …
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
GlobeNewswire
·
August 27, 2025
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The Wells …
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
GlobeNewswire
·
August 27, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 27, 2025
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
GlobeNewswire
·
August 27, 2025
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to accept its …
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 27, 2025
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investment Conference being held September 8-10, 2025, in New York, …